ESR1 and breast carcinoma: Recent studies have reported that LXR expression reduced the proliferative capacity of estrogen dependent HR+ cell lines in vitro [151,152]; however, this reduction was not evident in breast cancer mouse models where high levels of circulating cholesterol induced ER-dependent tumor growth and LXR-dependent metastasis [153].